Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
23-2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
23-2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #39906
advertisement
Zhang B
23
Showing records 1 to 23 |
Display all abstracts from
Zhang B
104481
A proposed theoretical framework for retinal biomarkers
MacCormick IJC
Alzheimer's & dementia (Amsterdam, Netherlands)
2022; 14: e12327
104861
Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Han R
Frontiers in public health
2022; 10: 944967
104797
The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Hu X; Zhang B
Eye
2023; 37: 607-617
104481
A proposed theoretical framework for retinal biomarkers
Zhang B
Alzheimer's & dementia (Amsterdam, Netherlands)
2022; 14: e12327
104861
Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Cheng G
Frontiers in public health
2022; 10: 944967
104481
A proposed theoretical framework for retinal biomarkers
Hill D
Alzheimer's & dementia (Amsterdam, Netherlands)
2022; 14: e12327
104861
Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Zhang B
Frontiers in public health
2022; 10: 944967
104481
A proposed theoretical framework for retinal biomarkers
Hill D
Alzheimer's & dementia (Amsterdam, Netherlands)
2022; 14: e12327
104797
The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li X
Eye
2023; 37: 607-617
104861
Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Yang J
Frontiers in public health
2022; 10: 944967
104797
The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li M
Eye
2023; 37: 607-617
104481
A proposed theoretical framework for retinal biomarkers
Cordeiro MF; Small DS
Alzheimer's & dementia (Amsterdam, Netherlands)
2022; 14: e12327
104797
The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Wang Y
Eye
2023; 37: 607-617
104861
Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Yuan M
Frontiers in public health
2022; 10: 944967
104797
The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Dan H
Eye
2023; 37: 607-617
104861
Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Yang D; Wu J
Frontiers in public health
2022; 10: 944967
104797
The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Zhou J; Wei Y
Eye
2023; 37: 607-617
104861
Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Liu J; Zhao C
Frontiers in public health
2022; 10: 944967
104797
The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Ge K
Eye
2023; 37: 607-617
104861
Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Chen Y
Frontiers in public health
2022; 10: 944967
104797
The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li P
Eye
2023; 37: 607-617
104861
Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Xu Y
Frontiers in public health
2022; 10: 944967
104797
The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Song Z
Eye
2023; 37: 607-617
Issue
23-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept